Comprehensive multi-omics analysis reveals m7G-related signature for evaluating prognosis and immunotherapy efficacy in osteosarcoma.

Zhang, Yiming; Gan, Wenyi; Ru, Nan; Xue, Zhaowen; Chen, Wenjie; Chen, Zihang; Wang, Huajun; Zheng, Xiaofei

Zhang, Yiming; Gan, Wenyi; Ru, Nan; Xue, Zhaowen; Chen, Wenjie; Chen, Zihang; Wang, Huajun; Zheng, Xiaofei.

Afiliación

Zhang Y; Department of Sports Medicine, The First Affiliated Hospital, Jinan University, Guangzhou 510000, China.
Gan W; Department of Sports Medicine, The First Affiliated Hospital, Jinan University, Guangzhou 510000, China.
Ru N; Department of Sports Medicine, The First Affiliated Hospital, Jinan University, Guangzhou 510000, China.
Xue Z; Department of Sports Medicine, The First Affiliated Hospital, Jinan University, Guangzhou 510000, China.
Chen W; Department of Sports Medicine, The First Affiliated Hospital, Jinan University, Guangzhou 510000, China.
Chen Z; Department of Sports Medicine, The First Affiliated Hospital, Jinan University, Guangzhou 510000, China.
Wang H; Department of Sports Medicine, The First Affiliated Hospital, Jinan University, Guangzhou 510000, China.
Zheng X; Department of Sports Medicine, The First Affiliated Hospital, Jinan University, Guangzhou 510000, China.

J Bone Oncol ; 40: 100481, 2023 Jun.

Article en En | MEDLINE | ID: mdl-37139222

Palabras clave

EIF4E3; Immunotherapy; M7G modification; Osteosarcoma; Single-cell analysis

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Tipo de estudio: Prognostic_studies Idioma: En Revista: J Bone Oncol Año: 2023 Tipo del documento: Article País de afiliación: China

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google